Based on current scientific knowledge, the pathophysiology of psoriasis involves an excessive release of pro-inflammatory molecules from the acquired immune system such as tumor necrosis factor alpha (TNF-α) and interleukins (IL), especially IL-17 and IL-23 (2). This evidence concerns the gene TNF and psoriasis.